239 related articles for article (PubMed ID: 10486155)
21. Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12.
Homma S; Komita H; Sagawa Y; Ohno T; Toda G
Immunology; 2005 Aug; 115(4):451-61. PubMed ID: 16011514
[TBL] [Abstract][Full Text] [Related]
22. Redirected perforin-dependent lysis of colon carcinoma by ex vivo genetically engineered CTL.
Darcy PK; Haynes NM; Snook MB; Trapani JA; Cerruti L; Jane SM; Smyth MJ
J Immunol; 2000 Apr; 164(7):3705-12. PubMed ID: 10725729
[TBL] [Abstract][Full Text] [Related]
23. T cell- and perforin-dependent depletion of B cells in vivo by staphylococcal enterotoxin A.
Sundstedt A; Grundström S; Dohlsten M
Immunology; 1998 Sep; 95(1):76-82. PubMed ID: 9767460
[TBL] [Abstract][Full Text] [Related]
24. Functional defects of NK cells treated with chloroquine mimic the lytic defects observed in perforin-deficient mice.
Austin Taylor M; Bennett M; Kumar V; Schatzle JD
J Immunol; 2000 Nov; 165(9):5048-53. PubMed ID: 11046034
[TBL] [Abstract][Full Text] [Related]
25. Influence of xenogeneic beta2-microglobulin on functional recognition of H-2Kb by the NK cell inhibitory receptor Ly49C.
Benoit LA; Shannon J; Chamberlain JW; Miller RG
J Immunol; 2005 Sep; 175(6):3542-53. PubMed ID: 16148097
[TBL] [Abstract][Full Text] [Related]
26. The CD8+ T cell repertoire in beta 2-microglobulin-deficient mice is biased towards reactivity against self-major histocompatibility class I.
Glas R; Ohlén C; Höglund P; Kärre K
J Exp Med; 1994 Feb; 179(2):661-72. PubMed ID: 8294874
[TBL] [Abstract][Full Text] [Related]
27. MRL/lpr CD4- CD8- and CD8+ T cells, respectively, mediate Fas-dependent and perforin cytotoxic pathways.
Benihoud K; Bonardelle D; Bobé P; Kiger N
Eur J Immunol; 1997 Feb; 27(2):415-20. PubMed ID: 9045912
[TBL] [Abstract][Full Text] [Related]
28. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
[TBL] [Abstract][Full Text] [Related]
29. Highly lytic CD8+, alpha beta T-cell receptor cytotoxic T cells with major histocompatibility complex (MHC) class I antigen-directed cytotoxicity in beta 2-microglobulin, MHC class I-deficient mice.
Apasov S; Sitkovsky M
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2837-41. PubMed ID: 8464897
[TBL] [Abstract][Full Text] [Related]
30. Mapping of quantitative trait loci determining NK cell-mediated resistance to MHC class I-deficient bone marrow grafts in perforin-deficient mice.
Johansson MH; Taylor MA; Jagodic M; Tus K; Schatzle JD; Wakeland EK; Bennett M
J Immunol; 2006 Dec; 177(11):7923-9. PubMed ID: 17114464
[TBL] [Abstract][Full Text] [Related]
31. Innate and adaptive immunity to tumors: IL-12 is required for optimal responses.
Grufman P; Kärre K
Eur J Immunol; 2000 Apr; 30(4):1088-93. PubMed ID: 10760797
[TBL] [Abstract][Full Text] [Related]
32. Perforin-dependent cytotoxic activity and lymphokine secretion by CD4+ T cells are regulated by CD8+ T cells.
Williams NS; Engelhard VH
J Immunol; 1997 Sep; 159(5):2091-9. PubMed ID: 9278294
[TBL] [Abstract][Full Text] [Related]
33. NK and CTL recognition of a single chain H-2Dd molecule: distinct sites of H-2Dd interact with NK and TCR.
Chung DH; Dorfman J; Plaksin D; Natarajan K; Belyakov IM; Hunziker R; Berzofsky JA; Yokoyama WM; Mage MG; Margulies DH
J Immunol; 1999 Oct; 163(7):3699-708. PubMed ID: 10490965
[TBL] [Abstract][Full Text] [Related]
34. The putative natural killer decoy early gene m04 (gp34) of murine cytomegalovirus encodes an antigenic peptide recognized by protective antiviral CD8 T cells.
Holtappels R; Thomas D; Podlech J; Geginat G; Steffens HP; Reddehase MJ
J Virol; 2000 Feb; 74(4):1871-84. PubMed ID: 10644360
[TBL] [Abstract][Full Text] [Related]
35. Development and antigen specificity of CD8+ cytotoxic T lymphocytes in beta 2-microglobulin-negative, MHC class I-deficient mice in response to immunization with tumor cells.
Apasov SG; Sitkovsky MV
J Immunol; 1994 Mar; 152(5):2087-97. PubMed ID: 8133027
[TBL] [Abstract][Full Text] [Related]
36. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
Tremblay N; Fontaine P; Perreault C
Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
[TBL] [Abstract][Full Text] [Related]
37. Positive selection of self- and alloreactive CD8+ T cells in Tap-1 mutant mice.
Aldrich CJ; Ljunggren HG; Van Kaer L; Ashton-Rickardt PG; Tonegawa S; Forman J
Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6525-8. PubMed ID: 8022816
[TBL] [Abstract][Full Text] [Related]
38. Tumor immunity in perforin-deficient mice: a role for CD95 (Fas/APO-1).
Rosen D; Li JH; Keidar S; Markon I; Orda R; Berke G
J Immunol; 2000 Mar; 164(6):3229-35. PubMed ID: 10706715
[TBL] [Abstract][Full Text] [Related]
39. MHC class Ia molecules alone control NK-mediated bone marrow graft rejection.
Grigoriadou K; Ménard C; Pérarnau B; Lemonnier FA
Eur J Immunol; 1999 Nov; 29(11):3683-90. PubMed ID: 10556824
[TBL] [Abstract][Full Text] [Related]
40. An essential role for tumor necrosis factor in natural killer cell-mediated tumor rejection in the peritoneum.
Smyth MJ; Kelly JM; Baxter AG; Körner H; Sedgwick JD
J Exp Med; 1998 Nov; 188(9):1611-9. PubMed ID: 9802973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
